Ankyrin repeat domain protein 2 and inhibitor of DNA binding 3 cooperatively inhibit myoblast differentiation by physical interaction.

Document Type

Article

Publication Date

8-23-2013

Keywords

Active Transport, Cell Nucleus, Animals, Cell Differentiation, Cell Nucleus, Cells, Cultured, Inhibitor of Differentiation Proteins, Mice, Mice, Transgenic, Muscle Proteins, Muscular Dystrophies, MyoD Protein, Myoblasts, Myositis, Promoter Regions, Genetic, Sterol Regulatory Element Binding Protein 1

JAX Source

J Biol Chem 2013 Aug 23; 288(34):24560-8.

ISSN

1083-351X

PMID

23824195

Abstract

Ankyrin repeat domain protein 2 (ANKRD2) translocates from the nucleus to the cytoplasm upon myogenic induction. Overexpression of ANKRD2 inhibits C2C12 myoblast differentiation. However, the mechanism by which ANKRD2 inhibits myoblast differentiation is unknown. We demonstrate that the primary myoblasts of mdm (muscular dystrophy with myositis) mice (pMB(mdm)) overexpress ANKRD2 and ID3 (inhibitor of DNA binding 3) proteins and are unable to differentiate into myotubes upon myogenic induction. Although suppression of either ANKRD2 or ID3 induces myoblast differentiation in mdm mice, overexpression of ANKRD2 and inhibition of ID3 or vice versa is insufficient to inhibit myoblast differentiation in WT mice. We identified that ANKRD2 and ID3 cooperatively inhibit myoblast differentiation by physical interaction. Interestingly, although MyoD activates the Ankrd2 promoter in the skeletal muscles of wild-type mice, SREBP-1 (sterol regulatory element binding protein-1) activates the same promoter in the skeletal muscles of mdm mice, suggesting the differential regulation of Ankrd2. Overall, we uncovered a novel pathway in which SREBP-1/ANKRD2/ID3 activation inhibits myoblast differentiation, and we propose that this pathway acts as a critical determinant of the skeletal muscle developmental program. J Biol Chem 2013 Aug 23; 288(34):24560-8.

Link to Full Text

Share

COinS